
The effect of zzso blockade on the risk of cardiovascular outcomes and long-term survival in patients with zzso arthritis zzso is not zzso We assembled a cohort of zzso zzso zzso zzso veterans who were diagnosed with zzso between October 1998 and September 2005, and who were treated with a zzso zzso drug zzso Cox survival models were built to examine the effect of zzso zzso on the risk of a composite zzso of cardiovascular outcomes defined as the occurrence of zzso heart disease, zzso heart failure, peripheral artery disease, or cerebrovascular disease, and on the risk of zzso Treatment with zzso zzso was not associated with a significant effect on the composite zzso of cardiovascular zzso When each outcome was examined zzso the use zzso zzso was not associated with an increased risk of zzso heart disease, zzso heart failure, or peripheral artery disease, but it was associated with decreased risk of cerebrovascular disease zzso ratio zzso zzso zzso confidence zzso zzso zzso zzso The use of zzso zzso did not affect the risk of death zzso zzso zzso zzso zzso zzso In zzso zzso the use zzso zzso was associated with a reduced risk of cardiovascular outcomes zzso zzso zzso zzso zzso zzso in patients younger than the median age of our cohort zzso zzso The use zzso zzso was not associated with a change in the risk of death in any other zzso These results show that the risk of cardiovascular events and survival in patients who receive zzso zzso is not different than those who receive other zzso 

